Basket | Login | Register


Brexpiprazole (coming soon)

Phase III trials

Scientific title

A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type

Study sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.


Subjects with agitation associated with dementia of the Alzheimer's type


Phase III

Name of drug


Link to full text

Please note that an accessible easy read version of this study is not yet available. The pharmaceutical company running this trial and a member of the European Working Group of People with Dementia are currently reviewing this document.



Last Updated: Wednesday 05 June 2019